SHARK
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK) (NCT07401875) | M.D. Anderson Cancer Center | 2026-03-24 |
Track SHARK automatically
Every clearance here is in the API, with alerts when new ones post.